Concepedia

Stefano Severi

SS

Statistics

Publications

35

Citations

2.1K

H-Index

26

Active since

2008

Affiliations

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori(Current)

Istituti di Ricovero e Cura a Carattere Scientifico

European Institute of Oncology

University of Ferrara

Erasmus MC

Stefano Severi is an author at Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

2008–2022

35

Publications

35

Role of 18FDG PET/CT in patients treated with 177Lu-DOTATATE for advanced differentiated neuroendocrine tumours

Stefano Severi, Oriana Nanni, Lisa Bodei et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2013 · 143 citations · Full text

, , +8

Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors

Lisa Bodei, Mark Kidd, Irvin Modlin et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2015 · 141 citations

, , +14

PRRT genomic signature in blood for prediction of 177Lu-octreotate efficacy

Lisa Bodei, Mark Kidd, Aviral Singh et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2018 · 128 citations

, , +10

177 Lu-Dota-octreotate radionuclide therapy of advanced gastrointestinal neuroendocrine tumors: results from a phase II study

Giovanni Paganelli, Maddalena Sansovini, A. Ambrosetti et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2014 · 121 citations

, , +11

Long-term follow-up and role of FDG PET in advanced pancreatic neuroendocrine patients treated with 177Lu-D OTATATE

Maddalena Sansovini, Stefano Severi, Annarita Ianniello et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2016 · 117 citations

, , +4

1–5 of 35